2016
DOI: 10.1016/j.surge.2015.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Surgical and endoscopic management of high grade dysplasia and early oesophageal adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 19 publications
(19 reference statements)
0
7
0
Order By: Relevance
“…Of the manuscripts focusing on RFA, 1 was a randomized controlled trial, 19 cohort observational studies, and 5 case series. Two cohort studies were included in only the recurrent dysplasia analysis as they did not report how many patients had recurrent IM 40 41 . The distribution of studies based on geographic location was as follows: USA (23), Europe (13), Australia (2), and Canada (1).…”
Section: Resultsmentioning
confidence: 99%
“…Of the manuscripts focusing on RFA, 1 was a randomized controlled trial, 19 cohort observational studies, and 5 case series. Two cohort studies were included in only the recurrent dysplasia analysis as they did not report how many patients had recurrent IM 40 41 . The distribution of studies based on geographic location was as follows: USA (23), Europe (13), Australia (2), and Canada (1).…”
Section: Resultsmentioning
confidence: 99%
“…A total of 69 studies met the eligibility criteria and included 33 002 patients with OAC from 53 studies and 2712 with OGJAC from 28 studies. These studies were published from 1978 to 2019 and were conducted in US/Canada (n = 25, 36.2%), 7,17,18,20‐41 Europe (n = 30, 43.5%), 42‐71 Asia (n = 11, 15.9%), 72‐82 Africa (n = 1, 1.4%), 83 South America (n = 1, 1.4%) 84 or Australia (n = 1, 1.4%) 85 and included 55 single‐centre (79.7%), 7 multi‐centre (10.1%) and seven population‐based studies (10.1%) (Tables 1 and 2). OAC and OGJAC determination was made using surgical or endoscopic specimens (n = 59 studies), diagnosis codes (n = 3 studies) or cancer registry (n = 7 studies).…”
Section: Resultsmentioning
confidence: 99%
“…The effectiveness of RFA in eradicating HG dysplasia ranges from 74.4% to 100%, and the success of eradication of IM ranges from 41% to 100% (Table 2) [8, 1025]. …”
Section: Treatment Efficacymentioning
confidence: 99%
“…The most common complication associated with esophageal RFA is posttreatment stricture formation with a reported incidence up to 19% [4, 8, 1016, 2125]. …”
Section: Complicationsmentioning
confidence: 99%